nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—CYP3A4—Temozolomide—melanoma	0.251	0.576	CbGbCtD
Tasosartan—CYP3A4—Vemurafenib—melanoma	0.137	0.316	CbGbCtD
Tasosartan—CYP3A4—Docetaxel—melanoma	0.0471	0.108	CbGbCtD
Tasosartan—Valsartan—ALB—melanoma	0.000965	0.373	CrCbGaD
Tasosartan—Candesartan—ABCB1—melanoma	0.000698	0.27	CrCbGaD
Tasosartan—Losartan—ALB—melanoma	0.000471	0.182	CrCbGaD
Tasosartan—Losartan—ABCB1—melanoma	0.00045	0.174	CrCbGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.00033	0.000587	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—E2F1—melanoma	0.000329	0.000585	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—WNT5A—melanoma	0.000328	0.000583	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CB—melanoma	0.000328	0.000583	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CUL3—melanoma	0.000327	0.000582	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TRRAP—melanoma	0.000327	0.000582	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PDGFRA—melanoma	0.000326	0.000579	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ITGB3—melanoma	0.000323	0.000573	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PRKCA—melanoma	0.000323	0.000573	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKR1B10—melanoma	0.000319	0.000566	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—F2R—melanoma	0.000317	0.000564	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SPP1—melanoma	0.000316	0.000562	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAP2K2—melanoma	0.000315	0.000561	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCL8—melanoma	0.000315	0.00056	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—EDNRB—melanoma	0.000307	0.000546	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL2—melanoma	0.000301	0.000535	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TERT—melanoma	0.0003	0.000533	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RAC1—melanoma	0.000299	0.000532	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—F2RL1—melanoma	0.000296	0.000527	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GNA11—melanoma	0.00029	0.000516	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GAB2—melanoma	0.00029	0.000516	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—F2R—melanoma	0.000288	0.000512	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HIF1A—melanoma	0.000287	0.00051	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—melanoma	0.000284	0.000506	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EDNRB—melanoma	0.000279	0.000496	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM3—melanoma	0.000278	0.000495	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KDR—melanoma	0.000274	0.000488	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCR4—melanoma	0.000273	0.000485	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—melanoma	0.000272	0.000484	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GNAQ—melanoma	0.00027	0.000479	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KISS1—melanoma	0.000264	0.000469	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FN1—melanoma	0.000264	0.000469	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GNA11—melanoma	0.000263	0.000468	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GAB2—melanoma	0.000263	0.000468	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000263	0.000467	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—melanoma	0.000259	0.000461	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—melanoma	0.000259	0.000461	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOTCH1—melanoma	0.000258	0.000459	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCR1—melanoma	0.000256	0.000455	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SKI—melanoma	0.000256	0.000455	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CD80—melanoma	0.000253	0.00045	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KIT—melanoma	0.000253	0.000449	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CG—melanoma	0.000253	0.000449	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APC—melanoma	0.000253	0.000449	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—NRAS—melanoma	0.000253	0.000449	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MC1R—melanoma	0.000252	0.000448	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—PIK3CA—melanoma	0.000251	0.000447	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGF—melanoma	0.00025	0.000444	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT3—melanoma	0.000249	0.000442	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCR4—melanoma	0.000248	0.00044	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GNAQ—melanoma	0.000245	0.000435	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—melanoma	0.000245	0.000435	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—MAPK3—melanoma	0.000242	0.00043	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR7—melanoma	0.000241	0.000429	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM1—melanoma	0.000241	0.000429	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—BRAF—melanoma	0.000237	0.000422	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—MDM2—melanoma	0.000235	0.000419	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SUFU—melanoma	0.000235	0.000418	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IGF1—melanoma	0.000231	0.000411	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—MAPK1—melanoma	0.00023	0.000409	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—EGFR—melanoma	0.00023	0.000409	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT3—melanoma	0.000226	0.000402	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	0.000225	0.0004	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAP2K1—melanoma	0.000224	0.000397	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CD—melanoma	0.000222	0.000395	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CA—melanoma	0.00022	0.000391	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BCL2L11—melanoma	0.00022	0.00039	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RHOB—melanoma	0.00022	0.00039	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—KRAS—melanoma	0.000217	0.000387	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FGF2—melanoma	0.000213	0.000378	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HDAC6—melanoma	0.000211	0.000375	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—EDN1—melanoma	0.000209	0.000372	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP17A1—melanoma	0.000208	0.00037	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	0.000208	0.00037	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	0.000205	0.000365	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CSF2—melanoma	0.000204	0.000363	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCR2—melanoma	0.0002	0.000356	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL8—melanoma	0.0002	0.000355	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CA—melanoma	0.0002	0.000355	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	0.000199	0.000354	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MDM2—melanoma	0.000199	0.000354	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RAC2—melanoma	0.000197	0.00035	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ERBB2—melanoma	0.000196	0.000349	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PRKCA—melanoma	0.000196	0.000348	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFC—melanoma	0.000194	0.000344	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—WNT5A—melanoma	0.000194	0.000344	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CB—melanoma	0.000194	0.000344	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EDN1—melanoma	0.00019	0.000338	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL8—melanoma	0.000186	0.000331	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CSF2—melanoma	0.000186	0.00033	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—HRAS—melanoma	0.000185	0.000329	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN1B—melanoma	0.000182	0.000323	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—RAC1—melanoma	0.000182	0.000323	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AKT1—melanoma	0.00018	0.000319	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CASP3—melanoma	0.000178	0.000317	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PRKCA—melanoma	0.000178	0.000316	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2—melanoma	0.000178	0.000316	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—melanoma	0.000177	0.000314	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP1B1—melanoma	0.000175	0.000312	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MAP2K2—melanoma	0.000174	0.000309	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCND1—melanoma	0.000173	0.000308	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	0.000173	0.000307	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CTNNB1—melanoma	0.000172	0.000305	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—F2R—melanoma	0.00017	0.000302	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP9—melanoma	0.000168	0.000299	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN1A—melanoma	0.000168	0.000298	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTEN—melanoma	0.000167	0.000297	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NFKB1—melanoma	0.000166	0.000296	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—RAC1—melanoma	0.000165	0.000293	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EDNRB—melanoma	0.000165	0.000293	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AKT1—melanoma	0.000163	0.00029	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTK2B—melanoma	0.00016	0.000284	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GAB2—melanoma	0.000156	0.000277	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GNA11—melanoma	0.000156	0.000277	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FLT1—melanoma	0.000155	0.000275	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CG—melanoma	0.000153	0.000273	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—melanoma	0.000151	0.000269	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—STAT3—melanoma	0.00015	0.000266	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NRAS—melanoma	0.000149	0.000265	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCR4—melanoma	0.000146	0.00026	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HDAC2—melanoma	0.000146	0.00026	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FOXO4—melanoma	0.000146	0.00026	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GNAQ—melanoma	0.000145	0.000257	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK3—melanoma	0.000143	0.000254	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CG—melanoma	0.000139	0.000248	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MYC—melanoma	0.000139	0.000247	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SYK—melanoma	0.000136	0.000242	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK1—melanoma	0.000136	0.000242	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGFR—melanoma	0.000136	0.000242	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CD—melanoma	0.000135	0.00024	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ITGAV—melanoma	0.000133	0.000237	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NGFR—melanoma	0.000133	0.000237	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT3—melanoma	0.000133	0.000237	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KRAS—melanoma	0.000128	0.000228	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SOCS1—melanoma	0.000124	0.00022	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MAP2K1—melanoma	0.000123	0.000219	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—S100B—melanoma	0.000123	0.000219	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CD—melanoma	0.000122	0.000218	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CA—melanoma	0.000118	0.00021	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ERBB4—melanoma	0.000118	0.00021	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CB—melanoma	0.000118	0.000209	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ACER3—melanoma	0.000117	0.000208	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN2B—melanoma	0.000117	0.000208	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TP53—melanoma	0.000114	0.000203	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CD86—melanoma	0.000113	0.000201	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL8—melanoma	0.000113	0.000201	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EDN1—melanoma	0.000112	0.000199	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CSF2—melanoma	0.00011	0.000195	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGF1—melanoma	0.00011	0.000195	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HRAS—melanoma	0.000109	0.000194	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2—melanoma	0.000108	0.000192	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—E2F1—melanoma	0.000107	0.000191	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—UGT2B10—melanoma	0.000107	0.00019	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CB—melanoma	0.000107	0.00019	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDGFRA—melanoma	0.000106	0.000189	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCA—melanoma	0.000105	0.000187	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ITGB3—melanoma	0.000105	0.000187	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—melanoma	0.000104	0.000186	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SPP1—melanoma	0.000103	0.000183	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAP2K2—melanoma	0.000103	0.000183	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL8—melanoma	0.000103	0.000182	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HS3ST5—melanoma	9.94e-05	0.000177	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2—melanoma	9.81e-05	0.000174	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TERT—melanoma	9.77e-05	0.000174	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RAC1—melanoma	9.74e-05	0.000173	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKT1—melanoma	9.64e-05	0.000171	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HIF1A—melanoma	9.34e-05	0.000166	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KDR—melanoma	8.94e-05	0.000159	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FN1—melanoma	8.6e-05	0.000153	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH1—melanoma	8.42e-05	0.00015	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CD80—melanoma	8.25e-05	0.000147	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CG—melanoma	8.23e-05	0.000146	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APC—melanoma	8.23e-05	0.000146	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KIT—melanoma	8.23e-05	0.000146	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NRAS—melanoma	8.23e-05	0.000146	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGF—melanoma	8.14e-05	0.000145	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MAPK3—melanoma	7.88e-05	0.00014	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BRAF—melanoma	7.74e-05	0.000138	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF1—melanoma	7.54e-05	0.000134	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLCB4—melanoma	7.53e-05	0.000134	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MAPK1—melanoma	7.5e-05	0.000133	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EGFR—melanoma	7.5e-05	0.000133	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAP2K1—melanoma	7.28e-05	0.000129	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CD—melanoma	7.24e-05	0.000129	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CA—melanoma	7.17e-05	0.000127	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KRAS—melanoma	7.08e-05	0.000126	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC6A11—melanoma	7.08e-05	0.000126	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIP4K2A—melanoma	7.08e-05	0.000126	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGF2—melanoma	6.93e-05	0.000123	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MTAP—melanoma	6.89e-05	0.000122	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CA—melanoma	6.51e-05	0.000116	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MDM2—melanoma	6.48e-05	0.000115	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ERBB2—melanoma	6.39e-05	0.000114	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CB—melanoma	6.31e-05	0.000112	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PHGDH—melanoma	6.14e-05	0.000109	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LUM—melanoma	6.14e-05	0.000109	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL8—melanoma	6.06e-05	0.000108	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HRAS—melanoma	6.02e-05	0.000107	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HPSE—melanoma	6.02e-05	0.000107	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN1B—melanoma	5.92e-05	0.000105	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CUBN—melanoma	5.91e-05	0.000105	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT1—melanoma	5.86e-05	0.000104	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASP3—melanoma	5.8e-05	0.000103	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2—melanoma	5.79e-05	0.000103	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—melanoma	5.76e-05	0.000102	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SDHD—melanoma	5.71e-05	0.000101	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CSPG4—melanoma	5.71e-05	0.000101	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—BSG—melanoma	5.71e-05	0.000101	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCND1—melanoma	5.65e-05	0.0001	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CTNNB1—melanoma	5.59e-05	9.94e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GPAM—melanoma	5.53e-05	9.83e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—melanoma	5.48e-05	9.75e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN1A—melanoma	5.46e-05	9.71e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTEN—melanoma	5.45e-05	9.69e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NFKB1—melanoma	5.42e-05	9.64e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT1—melanoma	5.32e-05	9.45e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—melanoma	4.92e-05	8.75e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT3—melanoma	4.87e-05	8.67e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NRAS—melanoma	4.86e-05	8.64e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLA2G6—melanoma	4.7e-05	8.36e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK3—melanoma	4.66e-05	8.28e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MYC—melanoma	4.53e-05	8.05e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK1—melanoma	4.43e-05	7.88e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGFR—melanoma	4.43e-05	7.88e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—VCAN—melanoma	4.22e-05	7.51e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KRAS—melanoma	4.19e-05	7.44e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CA—melanoma	3.85e-05	6.84e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TP53—melanoma	3.72e-05	6.61e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP17A1—melanoma	3.56e-05	6.33e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HRAS—melanoma	3.56e-05	6.32e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—melanoma	3.4e-05	6.05e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GNA11—melanoma	3.36e-05	5.98e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—FASN—melanoma	3.29e-05	5.85e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC5A5—melanoma	3.24e-05	5.76e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT1—melanoma	3.14e-05	5.58e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CD44—melanoma	3.13e-05	5.56e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GNAQ—melanoma	3.13e-05	5.56e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP1B1—melanoma	3e-05	5.33e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCB1—melanoma	2.47e-05	4.39e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PRKCA—melanoma	2.27e-05	4.04e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ERCC2—melanoma	2.25e-05	4.01e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CG—melanoma	1.78e-05	3.16e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARG—melanoma	1.72e-05	3.05e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CD—melanoma	1.56e-05	2.78e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—melanoma	1.54e-05	2.75e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CB—melanoma	1.36e-05	2.42e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—melanoma	1.35e-05	2.4e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTEN—melanoma	1.18e-05	2.1e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CA—melanoma	8.31e-06	1.48e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AKT1—melanoma	6.79e-06	1.21e-05	CbGpPWpGaD
